Clinical Trial Update: Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial evaluated combined effects of non-statin therapies on apolipoprotein A-I up-regulation in dyslipidemia; results have been posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: University of Pennsylvania | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2016-02-29